Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
116
1.960
Why?
Thyroidectomy
13
2019
61
1.800
Why?
Parathyroidectomy
8
2018
46
1.280
Why?
Thyroid Diseases
6
2019
27
1.230
Why?
Parathyroid Neoplasms
5
2015
27
1.070
Why?
Thyroid Gland
7
2017
78
1.020
Why?
Parathyroid Hormone
8
2019
149
0.950
Why?
Adenoma
4
2017
113
0.940
Why?
Vitamin D Deficiency
5
2019
46
0.940
Why?
Vitamin D
4
2015
90
0.810
Why?
Fluorodeoxyglucose F18
6
2013
188
0.730
Why?
Positron-Emission Tomography
7
2013
301
0.710
Why?
Radiopharmaceuticals
7
2015
204
0.700
Why?
Carcinoma, Papillary
4
2017
51
0.700
Why?
Ambulatory Surgical Procedures
4
2014
52
0.680
Why?
Hyperparathyroidism, Primary
4
2018
35
0.650
Why?
Hyperparathyroidism
2
2015
31
0.580
Why?
Iodine Radioisotopes
3
2015
34
0.560
Why?
Megestrol Acetate
2
2007
17
0.520
Why?
Parathyroid Diseases
2
2016
5
0.520
Why?
Bone Density Conservation Agents
2
2007
75
0.500
Why?
Nursing Homes
2
2007
112
0.500
Why?
Incidental Findings
3
2013
43
0.470
Why?
Proton Pump Inhibitors
1
2015
86
0.470
Why?
Diphosphonates
1
2015
92
0.460
Why?
Academic Medical Centers
2
2012
151
0.450
Why?
Thyroglobulin
2
2013
7
0.450
Why?
Parathyroid Glands
5
2018
20
0.430
Why?
Carcinoma, Medullary
2
2010
12
0.420
Why?
Aged
19
2017
10121
0.420
Why?
Middle Aged
25
2017
13028
0.410
Why?
Hypothyroidism
2
2011
57
0.380
Why?
Male
31
2019
26761
0.370
Why?
Retrospective Studies
14
2019
6607
0.370
Why?
Calcitonin
2
2010
30
0.360
Why?
Postoperative Complications
5
2018
1068
0.360
Why?
Carcinoma
2
2012
138
0.340
Why?
Humans
44
2019
52483
0.340
Why?
Algorithms
1
2013
672
0.330
Why?
Thyroid Nodule
3
2017
31
0.320
Why?
Female
29
2019
28171
0.300
Why?
Weight Loss
2
2009
248
0.300
Why?
Appetite Stimulants
1
2007
5
0.280
Why?
Cachexia
1
2007
27
0.270
Why?
Teriparatide
1
2007
10
0.270
Why?
Aged, 80 and over
9
2017
3392
0.270
Why?
Four-Dimensional Computed Tomography
2
2017
28
0.250
Why?
Calcium
3
2018
376
0.250
Why?
Hypocalcemia
2
2016
13
0.250
Why?
Pituitary Hormones, Anterior
1
2005
4
0.250
Why?
Phenylurea Compounds
2
2015
17
0.240
Why?
Hormones
1
2005
59
0.240
Why?
Osteoporosis
1
2007
162
0.240
Why?
Quinolines
2
2015
44
0.240
Why?
Transcriptional Activation
1
2005
122
0.240
Why?
Pituitary Gland
1
2005
88
0.230
Why?
Receptors, Estrogen
1
2005
131
0.230
Why?
Interleukin-6
1
2005
278
0.220
Why?
NF-kappa B
1
2005
322
0.210
Why?
Biopsy, Fine-Needle
5
2011
107
0.210
Why?
Protein Kinase Inhibitors
2
2015
227
0.210
Why?
Illinois
2
2013
11
0.200
Why?
Treatment Outcome
8
2015
5422
0.190
Why?
Adult
13
2017
14161
0.180
Why?
Gene Expression Regulation
1
2005
990
0.170
Why?
Aging
1
2005
701
0.170
Why?
Young Adult
7
2015
4329
0.170
Why?
Follow-Up Studies
3
2013
2279
0.160
Why?
Hyperparathyroidism, Secondary
1
2019
4
0.160
Why?
Postoperative Period
3
2015
170
0.150
Why?
Preoperative Care
2
2018
173
0.140
Why?
Vitamins
2
2018
64
0.140
Why?
Patient Discharge
3
2016
330
0.140
Why?
Intraoperative Complications
1
2019
112
0.140
Why?
Insulin Resistance
2
2009
275
0.140
Why?
Prospective Studies
2
2013
2481
0.130
Why?
United States
5
2015
5192
0.130
Why?
Antineoplastic Agents
2
2015
1222
0.130
Why?
Predictive Value of Tests
3
2015
944
0.130
Why?
Reoperation
1
2018
465
0.130
Why?
Incidence
2
2011
1062
0.130
Why?
Hypoparathyroidism
1
2015
5
0.120
Why?
Carcinoma, Neuroendocrine
1
2015
25
0.120
Why?
Adolescent
5
2015
6739
0.120
Why?
Creatinine
1
2015
150
0.120
Why?
Tomography, Emission-Computed, Single-Photon
1
2015
52
0.120
Why?
Costs and Cost Analysis
2
2014
95
0.120
Why?
Lymph Nodes
1
2017
258
0.120
Why?
Disease Progression
3
2015
871
0.120
Why?
Molecular Targeted Therapy
1
2015
133
0.110
Why?
Diagnosis, Differential
6
2018
1046
0.110
Why?
Ambulatory Care
1
2016
239
0.110
Why?
Neoplasm Metastasis
2
2015
243
0.110
Why?
Hospitals, University
1
2014
75
0.110
Why?
Child, Preschool
2
2013
4076
0.110
Why?
Sensitivity and Specificity
2
2013
891
0.100
Why?
Liver
2
2009
1156
0.100
Why?
Exercise
2
2009
547
0.100
Why?
Drug Administration Schedule
1
2013
374
0.100
Why?
Hospitals, Teaching
1
2013
54
0.100
Why?
Technetium
1
2012
8
0.100
Why?
Preoperative Period
1
2012
46
0.100
Why?
Administration, Oral
1
2013
451
0.100
Why?
Radionuclide Imaging
1
2012
107
0.100
Why?
Patient Compliance
1
2013
230
0.100
Why?
Clinical Competence
2
2018
406
0.100
Why?
Outpatients
1
2013
125
0.100
Why?
Hospital Charges
1
2012
46
0.100
Why?
Struma Ovarii
1
2012
5
0.100
Why?
Tumor Burden
1
2012
136
0.100
Why?
Cost Savings
1
2012
58
0.100
Why?
Ovariectomy
1
2012
113
0.090
Why?
Prognosis
3
2015
2099
0.090
Why?
Child
3
2013
7248
0.090
Why?
Immunohistochemistry
2
2012
979
0.090
Why?
Chromogranin A
1
2010
5
0.090
Why?
Obesity
2
2009
1162
0.090
Why?
Dose-Response Relationship, Drug
1
2013
1378
0.080
Why?
Radiation Monitoring
1
2010
7
0.080
Why?
Inpatients
1
2011
205
0.080
Why?
Checklist
1
2010
40
0.080
Why?
Fatal Outcome
1
2010
197
0.080
Why?
Radiosurgery
1
2011
131
0.080
Why?
Databases, Factual
1
2013
706
0.080
Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
Why?
Caloric Restriction
1
2009
38
0.080
Why?
Ultrasonography
4
2015
430
0.080
Why?
Intra-Abdominal Fat
1
2009
21
0.080
Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
Why?
General Surgery
1
2010
105
0.080
Why?
Occupational Exposure
1
2010
111
0.070
Why?
Blastomycosis
1
2008
31
0.070
Why?
Receptors, Thyrotropin
1
2007
6
0.070
Why?
Symporters
1
2007
15
0.070
Why?
Adenoma, Oxyphilic
1
2007
11
0.070
Why?
Time Factors
3
2015
2968
0.070
Why?
Ovarian Neoplasms
1
2012
459
0.070
Why?
Anorexia
1
2007
7
0.070
Why?
Whole Body Imaging
1
2007
26
0.070
Why?
Severity of Illness Index
1
2011
1026
0.070
Why?
Adiposity
1
2009
143
0.070
Why?
DNA, Neoplasm
1
2007
146
0.070
Why?
Calcifediol
1
2006
8
0.070
Why?
Practice Management, Medical
1
2006
10
0.070
Why?
Calcium Carbonate
1
2006
11
0.070
Why?
Medical Audit
1
2006
22
0.070
Why?
Promoter Regions, Genetic
2
2007
467
0.070
Why?
Drug Utilization Review
1
2006
22
0.070
Why?
Drug Monitoring
1
2006
83
0.060
Why?
Head
1
2006
70
0.060
Why?
Geriatrics
1
2006
47
0.060
Why?
Cross-Sectional Studies
2
2014
1678
0.060
Why?
Gene Expression Regulation, Neoplastic
1
2010
857
0.060
Why?
Otolaryngology
1
2006
61
0.060
Why?
Body Mass Index
2
2009
689
0.060
Why?
Neck
1
2006
97
0.060
Why?
Proportional Hazards Models
1
2007
443
0.060
Why?
Progesterone Congeners
1
2005
5
0.060
Why?
Body Fat Distribution
1
2005
10
0.060
Why?
Freezing
1
2005
16
0.060
Why?
Faculty, Medical
1
2006
91
0.060
Why?
Arkansas
2
2014
2028
0.060
Why?
Serum
1
2005
32
0.060
Why?
Fractures, Bone
1
2006
107
0.060
Why?
Survival Analysis
1
2007
673
0.060
Why?
DNA Primers
1
2005
208
0.060
Why?
Reproducibility of Results
3
2017
1229
0.060
Why?
Internship and Residency
1
2010
448
0.060
Why?
HeLa Cells
1
2005
265
0.060
Why?
Base Sequence
1
2005
640
0.060
Why?
Nuclear Proteins
1
2005
245
0.050
Why?
Protein Binding
1
2005
667
0.050
Why?
Infant
1
2012
3733
0.050
Why?
ROC Curve
2
2015
253
0.050
Why?
Patient Selection
2
2018
259
0.050
Why?
Intraoperative Period
2
2015
46
0.050
Why?
Randomized Controlled Trials as Topic
1
2005
595
0.050
Why?
Tomography, X-Ray Computed
3
2012
1165
0.040
Why?
Thalidomide
1
2002
377
0.040
Why?
Glucagon
2
2009
24
0.040
Why?
Cohort Studies
2
2015
1542
0.040
Why?
Monitoring, Intraoperative
1
2019
54
0.040
Why?
Cholecalciferol
1
2018
22
0.040
Why?
Hospitals, High-Volume
1
2018
25
0.040
Why?
Medical History Taking
1
2018
47
0.040
Why?
Risk Factors
1
2006
3889
0.040
Why?
Pilot Projects
2
2010
721
0.040
Why?
Methylene Blue
1
2017
9
0.030
Why?
Lymphatic System
1
2017
16
0.030
Why?
Animals, Genetically Modified
1
2017
52
0.030
Why?
Societies, Medical
1
2018
200
0.030
Why?
Coloring Agents
1
2017
69
0.030
Why?
Mice, Inbred Strains
1
2017
163
0.030
Why?
Proto-Oncogene Proteins B-raf
1
2017
81
0.030
Why?
Insulin
2
2009
479
0.030
Why?
Recurrence
1
2018
672
0.030
Why?
Lymphatic Metastasis
1
2017
220
0.030
Why?
Bone Density
1
2018
399
0.030
Why?
Technetium Tc 99m Sestamibi
1
2015
18
0.030
Why?
Retreatment
1
2015
58
0.030
Why?
Brachial Plexus
1
2015
12
0.030
Why?
Endocrinology
1
2015
11
0.030
Why?
Axilla
1
2015
92
0.030
Why?
Hematoma
1
2015
65
0.030
Why?
Transplantation, Autologous
1
2015
488
0.030
Why?
Neoplasm Staging
1
2015
772
0.030
Why?
Hernia, Abdominal
1
2012
4
0.020
Why?
Activating Transcription Factor 1
1
2012
22
0.020
Why?
Delayed Diagnosis
1
2012
30
0.020
Why?
Mutation
1
2017
1347
0.020
Why?
Ribs
1
2010
16
0.020
Why?
Thoracotomy
1
2010
33
0.020
Why?
Neck Dissection
1
2010
29
0.020
Why?
Mediastinal Neoplasms
1
2010
18
0.020
Why?
Hypercalcemia
1
2010
34
0.020
Why?
Feasibility Studies
1
2011
406
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2009
69
0.020
Why?
Octreotide
1
2009
9
0.020
Why?
Hospitalization
1
2014
736
0.020
Why?
Glucose Tolerance Test
1
2009
60
0.020
Why?
Prevalence
1
2012
1006
0.020
Why?
Adiponectin
1
2009
46
0.020
Why?
Postmenopause
1
2009
82
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
235
0.020
Why?
Absorptiometry, Photon
1
2009
162
0.020
Why?
Eye
1
2008
25
0.020
Why?
Bone Neoplasms
1
2010
184
0.020
Why?
Iodine
1
2007
12
0.020
Why?
Methylation
1
2007
126
0.020
Why?
Body Weight
1
2009
523
0.020
Why?
Neoplasm Recurrence, Local
1
2011
649
0.020
Why?
Overweight
1
2009
224
0.020
Why?
Multiple Myeloma
1
2002
3049
0.020
Why?
Current Procedural Terminology
1
2006
11
0.020
Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
Why?
Office Visits
1
2006
45
0.020
Why?
Mice
1
2017
5949
0.020
Why?
Polymerase Chain Reaction
1
2007
461
0.020
Why?
Genetic Predisposition to Disease
1
2009
528
0.020
Why?
Blood Glucose
1
2009
473
0.020
Why?
Risk Assessment
1
2010
1327
0.010
Why?
Lung
1
2008
509
0.010
Why?
Muscle, Skeletal
1
2009
804
0.010
Why?
Thyroid Function Tests
1
2002
27
0.010
Why?
Thyrotropin
1
2002
49
0.010
Why?
Animals
1
2017
13505
0.010
Why?
Clinical Trials as Topic
1
2002
467
0.010
Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description